BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22086928)

  • 1. Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family.
    Garcia BL; Summers BJ; Lin Z; Ramyar KX; Ricklin D; Kamath DV; Fu ZQ; Lambris JD; Geisbrecht BV
    J Biol Chem; 2012 Jan; 287(1):628-640. PubMed ID: 22086928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.
    Garcia BL; Ramyar KX; Tzekou A; Ricklin D; McWhorter WJ; Lambris JD; Geisbrecht BV
    J Mol Biol; 2010 Sep; 402(1):17-29. PubMed ID: 20654625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.
    Garcia BL; Summers BJ; Ramyar KX; Tzekou A; Lin Z; Ricklin D; Lambris JD; Laity JH; Geisbrecht BV
    J Biol Chem; 2013 Jan; 288(4):2870-81. PubMed ID: 23233676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
    Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
    Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization of human complement component C3b in the presence of a staphylococcal complement-inhibitor protein (SCIN).
    Garcia BL; Tzekou A; Ramyar KX; McWhorter WJ; Ricklin D; Lambris JD; Geisbrecht BV
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 May; 65(Pt 5):482-5. PubMed ID: 19407382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a staphylococcal complement inhibitor with broad host specificity in equid
    de Jong NWM; Vrieling M; Garcia BL; Koop G; Brettmann M; Aerts PC; Ruyken M; van Strijp JAG; Holmes M; Harrison EM; Geisbrecht BV; Rooijakkers SHM
    J Biol Chem; 2018 Mar; 293(12):4468-4477. PubMed ID: 29414776
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.
    Summers BJ; Garcia BL; Woehl JL; Ramyar KX; Yao X; Geisbrecht BV
    Mol Immunol; 2015 Oct; 67(2 Pt B):193-205. PubMed ID: 26052070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human monoclonal antibody that specifically binds and inhibits the staphylococcal complement inhibitor protein SCIN.
    Hoekstra H; Romero Pastrana F; Bonarius HPJ; van Kessel KPM; Elsinga GS; Kooi N; Groen H; van Dijl JM; Buist G
    Virulence; 2018 Jan; 9(1):70-82. PubMed ID: 28277903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
    Ricklin D; Tzekou A; Garcia BL; Hammel M; McWhorter WJ; Sfyroera G; Wu YQ; Holers VM; Herbert AP; Barlow PN; Geisbrecht BV; Lambris JD
    J Immunol; 2009 Aug; 183(4):2565-74. PubMed ID: 19625656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of C3b in complex with CRIg gives insights into regulation of complement activation.
    Wiesmann C; Katschke KJ; Yin J; Helmy KY; Steffek M; Fairbrother WJ; McCallum SA; Embuscado L; DeForge L; Hass PE; van Lookeren Campagne M
    Nature; 2006 Nov; 444(7116):217-20. PubMed ID: 17051150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric inhibition of complement function by a staphylococcal immune evasion protein.
    Chen H; Ricklin D; Hammel M; Garcia BL; McWhorter WJ; Sfyroera G; Wu YQ; Tzekou A; Li S; Geisbrecht BV; Woods VL; Lambris JD
    Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17621-6. PubMed ID: 20876141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.
    Krishnan V; Ponnuraj K; Xu Y; Macon K; Volanakis JE; Narayana SV
    Structure; 2009 Apr; 17(4):611-9. PubMed ID: 19368894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal complement evasion by various convertase-blocking molecules.
    Jongerius I; Köhl J; Pandey MK; Ruyken M; van Kessel KP; van Strijp JA; Rooijakkers SH
    J Exp Med; 2007 Oct; 204(10):2461-71. PubMed ID: 17893203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal complement inhibitor: structure and active sites.
    Rooijakkers SH; Milder FJ; Bardoel BW; Ruyken M; van Strijp JA; Gros P
    J Immunol; 2007 Sep; 179(5):2989-98. PubMed ID: 17709514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases.
    Jongerius I; Puister M; Wu J; Ruyken M; van Strijp JA; Rooijakkers SH
    J Immunol; 2010 Jan; 184(1):420-5. PubMed ID: 19949103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
    Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
    Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
    J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
    Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
    Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion.
    Laarman AJ; Ruyken M; Malone CL; van Strijp JA; Horswill AR; Rooijakkers SH
    J Immunol; 2011 Jun; 186(11):6445-53. PubMed ID: 21502375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.